Government

This column discusses where the USDA went wrong in their final rule regarding hemp and how the author thinks it can be fixed.

Here we take a closer look at the cannabis industry in Canada and speak to several Canadians involved in the industry.

A discussion on how extractors need to monitor the chemical processes they perform.

Congress passes the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act and the Medical Marijuana Research Act in two historic votes, signifying a growing shift toward cannabis legalization.

How will the need for increased testing impact extractors?

Ann M. Brum and Wayne Smith discuss their roles as cannabis advocates fighting for reform and veteran access to medical cannabis.

What does FDA oversight mean for cannabis businesses and the industry as a whole?

The U.S. House of Representatives will be voting on a historic cannabis legalization bill in September, titled the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act.

The U.S. Department of Agriculture (USDA) recently issued a temporary delay regarding enforcement on two provisions of its hemp regulations (1).

On Tuesday, December 3, 2019, Brazil’s pharmaceutical regulator Avinsa approved regulations for the roll-out of medicinal cannabis-based products.

November 20, 2019 marked a monumental day in the prohibition of cannabis. The House Judiciary Committee (1) approved a bill that would federally decriminalize cannabis by removing it from the Controlled Substance Act and expunge particular crimes related to marijuana.

The U.S. Secretary of Agriculture, Sonny Perdue, announced the establishment of the U.S. Domestic Hemp Production Program on October 29, 2019.  

A number of causes of hemp testing insanity are documented such as different states using different THC measures to determine legality, lack of representative sampling, and more.

According to a press release from the National Cannabis Industry Association (NCIA), a standalone cannabis policy reform bill was brought before the House of Representatives for a vote on Wednesday, September 25, 2019 and passed with an overwhelming bipartisan majority.

Here we take a closer look at Australia’s medical cannabis program, the laws surrounding it, and speak to Australian pharmacist Paul Mavor.

A look at energy consumption in the cannabis industry and suggestions on how cultivator’s can reduce those costs.

Compact mass spectrometry, in combination with suitable sample introduction techniques-such as the atmospheric solids analysis probe, thin-layer chromatography, and classical liquid chromatography techniques-can be used effectively for the detection and quantification of cannabinoids and pesticides in cannabis-related material and contraband.

The agencies sent warning letters to several companies that the agencies say are illegally marketing unapproved products to treat opioid addiction and withdrawal.

An interview with Sue Sisley

An interview with Montel Williams

An interview with Uma Dhanabalan